XML 22 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 1,105 $ 943
Accounts and notes receivable, net 511 674
Inventories 939 1,079
Prepaid expenses and other 78 81
Total current assets 2,633 2,777
Property, plant, and equipment 9,582 9,413
Less: Accumulated depreciation (6,108) (5,854)
Property, plant, and equipment, net 3,474 3,559
Operating lease right-of-use assets 236 294
Goodwill, net 153 153
Other intangible assets, net 14 21
Investments in affiliates 167 162
Other assets 405 292
Total assets 7,082 7,258
Current liabilities:    
Accounts payable 844 923
Short-term and current maturities of long-term debt 21 134
Other accrued liabilities 577 484
Total current liabilities 1,442 1,541
Long-term debt, net 4,005 4,026
Operating lease liabilities 194 245
Deferred income taxes 36 118
Other liabilities 590 633
Total liabilities 6,267 6,563
Commitments and contingent liabilities
Equity    
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 190,239,883 shares issued and 164,920,648 shares outstanding at December 31, 2020; 188,893,478 shares issued and 163,574,243 shares outstanding at December 31, 2019) 2 2
Treasury stock, at cost (25,319,235 shares at December 31, 2020 and 2019) (1,072) (1,072)
Additional paid-in capital 890 859
Retained earnings 1,303 1,249
Accumulated other comprehensive loss (310) (349)
Total Chemours stockholders’ equity 813 689
Non-controlling interests 2 6
Total equity 815 695
Total liabilities and equity $ 7,082 $ 7,258